“The largest diagnostic market ever, the Home Diagnostics market is opening up. Players large and small are jockeying for position. Opportunities abound as this new market gains steam…..”
Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis and Executive Guides, 2024 to 2028
Howe Sound Research Published April 2024 – 409 pages
Rapid at home testing opens up new market.
Genetic DTC testing led the way. Now diagnostic testing is moving directly to the consumer. New technology has changed the picture on how and where testing is done. This report explores the outlook for all manner of At Home Diagnostics. Find out where the action is and the learn about the players.
Exciting technical developments especially in the seesaw between different analytic technology, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even newer technology is on the horizon.
The report has hundreds of pages of information.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
Our reports are sold on a 12 Month Subscription basis. Buying a report entitles you to the original current report plus an additional 1 to 3 follow on updated reports.
1 Market Guides …………………………………………………………………………………………………… 19
1.1 Situation Analysis ……………………………………………………………………………………………….. 20
1.2 Guide for Executives and Marketing Staff …………………………………………………………… 22
1.3 Guide for Investment Analysts and Management Consultants …………………………….. 23
2 Introduction and Market Definition …………………………………………………………………….. 24
2.1 What are Home Diagnostics? …………………………………………………………………………….. 25
2.2 Home Testing – the quiet revolution in diagnostics ………………………………………………. 26
2.3 Self vs. Send vs. In House – Who knew? ……………………………………………………………….. 27
2.3.1 Self ………………………………………………………………………………………………………………… 27
2.3.2 Send………………………………………………………………………………………………………………. 28
2.3.3 In-House ………………………………………………………………………………………………………… 28
2.4 Market Definition ……………………………………………………………………………………………….. 28
2.4.1 Retail vs. Wholesale ………………………………………………………………………………………… 29
2.5 Application Segments ……………………………………………………………………………………….. 30
2.5.1 Channel Segments …………………………………………………………………………………………. 30
2.5.2 Technology Segments ……………………………………………………………………………………. 31
2.5.3 Currency ……………………………………………………………………………………………………….. 31
2.5.4 Years ……………………………………………………………………………………………………………… 31
2.6 Methodology …………………………………………………………………………………………………….. 32
2.6.1 Methodology …………………………………………………………………………………………………. 32
2.6.2 Sources ………………………………………………………………………………………………………….. 32
2.6.3 Authors ………………………………………………………………………………………………………….. 32
2.7 Perspective: Healthcare and the IVD Industry …………………………………………………….. 34
2.7.1 Global Healthcare Spending ………………………………………………………………………….. 34
2.7.2 Spending on Diagnostics ………………………………………………………………………………… 35
2.7.3 Important Role of Insurance for Diagnostics …………………………………………………….. 37
3 Industry Overview ………………………………………………………………………………………………. 38
3.1 Players in a Dynamic Market ………………………………………………………………………………. 39
3.1.1 Academic Research Lab ……………………………………………………………………………….. 40
3.1.2 Diagnostic Test Developer ………………………………………………………………………………. 41
3.1.3 Instrumentation Supplier …………………………………………………………………………………. 41
3.1.4 Chemical/Reagent Supplier ……………………………………………………………………………. 41
3.1.5 Pathology Supplier …………………………………………………………………………………………. 41
3.1.6 Independent Clinical Laboratory ……………………………………………………………………. 42
3.1.7 Public National/regional Laboratory ……………………………………………………………….. 42
3.1.8 Hospital Laboratory ………………………………………………………………………………………… 43
3.1.9 Physicians Office Lab (POLS) …………………………………………………………………………… 43
3.1.10 Audit Body ………………………………………………………………………………………………….. 44
3.1.11 Certification Body ……………………………………………………………………………………….. 44
3.2 Diagnostic Market Segments ……………………………………………………………………………… 46
3.2.1 Traditional Market Segmentation…………………………………………………………………….. 46
3.2.2 Laboratory Focus and Segmentation ………………………………………………………………. 47
3.2.3 Segmenting the Home Diagnostics Market ……………………………………………………… 48
3.3 Industry Structure ……………………………………………………………………………………………….. 50
3.3.1 Hospital Testing Share …………………………………………………………………………………….. 50
3.3.2 Economies of Scale ………………………………………………………………………………………… 50
3.3.3 Hospital vs. Central Lab ………………………………………………………………………………….. 51
3.3.4 Physician Office Lab’s …………………………………………………………………………………….. 52
3.3.4.1 The Problem with POLS …………………………………………………………………………….. 52
3.3.5 Physician’s and Home Diagnostics ………………………………………………………………….. 53
3.3.6 Pharmacies and Home Diagnostics ………………………………………………………………… 53
3.3.6.1 The Diagnostic Plight of Pharmacies – Trying to do good …………………………… 53
3.3.6.2 The Theranos Legacy ………………………………………………………………………………. 54
4 Market Trends ……………………………………………………………………………………………………. 55
4.1 Factors Driving Growth ………………………………………………………………………………………. 56
4.1.1 Privacy and Anonymity …………………………………………………………………………………… 56
4.1.2 The Internet Effect ………………………………………………………………………………………….. 56
4.1.3 Rapid Result …………………………………………………………………………………………………… 57
4.1.4 The Wellness Movement …………………………………………………………………………………. 57
4.1.5 The COVID-19 Impact …………………………………………………………………………………….. 57
4.2 Factors Limiting Growth ……………………………………………………………………………………… 59
4.2.1 Trust Factor …………………………………………………………………………………………………….. 59
4.2.2 Infectious Disease is Declining But…. ……………………………………………………………….. 61
4.2.3 Wellness Hurts …………………………………………………………………………………………………. 61
4.2.4 Economic Growth improves Living Standards ………………………………………………….. 61
4.3 Diagnostic Technology Development ………………………………………………………………… 62
4.3.1 The Multiplex Paradigm Shift……………………………………………………………………………. 62
4.3.2 NAT vs. Lateral Flow ………………………………………………………………………………………… 64
4.3.3 The Unusual Role of GPS …………………………………………………………………………………. 64
4.3.4 Self and Send Competition …………………………………………………………………………….. 64
4.3.5 The Relationship to DTC Genetic …………………………………………………………………….. 65
4.3.6 The Relationship to TeleHealth ………………………………………………………………………… 66
4.3.7 Sample Collection – Who Knew? …………………………………………………………………….. 66
5 Home Diagnostics Recent Developments …………………………………………………………… 67
5.1 Recent Developments – Importance and How to Use This Section ………………………. 68
5.1.1 Importance of These Developments ……………………………………………………………….. 68
5.1.2 How to Use This Section …………………………………………………………………………………… 68
5.2 Watmind Get Two EUAs ……………………………………………………………………………………… 68
5.3 Capitainer, Life Genomics Partner on Self-Sampling Diagnostics ………………………….. 69
5.4 MyGeneticScreen Home Test Launched …………………………………………………………….. 70
5.5 Demand for OTC Self-Tests Tempered by Lack of Reimbursement ……………………….. 70
5.6 DiaCarta OTC Fecal Occult Blood Test Receives FDA Approval …………………………… 78
5.7 LetsGetChecked Nabs FDA Authorization for Chlamydia, Gonorrhea Test …………… 78
5.8 DiagMetrics Developing Breath Assays ……………………………………………………………….. 79
5.9 Co-Diagnostics Awarded $2.3M for TB, HPV Tests ………………………………………………… 82
5.10 POC Developers Nuclein and Minute Molecular Dx Merge………………………………….. 83
5.11 ReadyGo Dx to Make MDx Testing a ‘Snap’ ………………………………………………………… 84
5.12 Altratech Enters POC Testing Space by Supplanting PCR …………………………………….. 88
5.13 Sherlock Biosciences to Acquire Sense Biodetection …………………………………………… 92
5.14 Scripps Research, Cue Health to Offer Home Based Test-to-Treat Program …………… 93
5.15 KSL Pulse Scientific to Distribute Home Molecular Test in Canada ………………………… 96
5.16 Juno Diagnostics Offers NIPT With At-Home Sample Collection ……………………………. 97
5.17 Sherlock Biosciences Adds to Diagnostic Toolkit ………………………………………………… 100
5.18 Morgan Health Invests in LetsGetChecked ……………………………………………………….. 103
5.19 Prenetics ColoClear by Circle …………………………………………………………………………… 104
5.20 Detect to Roll Out Next-Gen Molecular Instrument ……………………………………………. 104
5.21 Diagnostics for the Real World Third-Generation POC Platform ………………………….. 107
5.22 Labcorp Partnering With Getlabs for Home Collection ………………………………………. 111
5.23 Salignostics Closes Funding Round ……………………………………………………………………. 111
5.24 Cue Health Targets DTC Market in 2022 …………………………………………………………….. 112
5.25 Grip Molecular Developing Home Respiratory Panel …………………………………………. 115
5.26 Mainz Biomed Developing Home ColoAlert Assay …………………………………………….. 119
5.27 MFB Fertility Closes Series A Financing Round …………………………………………………….. 123
5.28 Continued Demand for SARS-CoV-2 Rapid Tests ……………………………………………….. 124
5.29 Rapid Covid-19 Test Results Risk Going Uncounted ……………………………………………. 125
5.30 FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit …………………………………… 127
5.31 Researchers Develop 15-Minute PCR System …………………………………………………….. 128
5.32 Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test …………………………. 130
5.33 Lucira Health Files for $115M IPO ………………………………………………………………………. 135
5.34 Spectrum Solutions Gets CE Mark for Saliva Collection Devices …………………………. 136
6 Profiles of Key Home Diagnostics Companies ……………………………………………………. 137
6.1 1DropDiagnostics …………………………………………………………………………………………….. 138
6.2 23andME Inc. …………………………………………………………………………………………………… 139
6.3 Abbott Laboratories …………………………………………………………………………………………. 140
6.4 Accel Diagnostics ……………………………………………………………………………………………. 142
6.5 ADT Biotech …………………………………………………………………………………………………….. 144
6.6 Akonni Biosystems ……………………………………………………………………………………………. 145
6.7 AlphaBiolabs ……………………………………………………………………………………………………. 146
6.8 Alveo Technologies ………………………………………………………………………………………….. 148
6.9 Anitoa ……………………………………………………………………………………………………………… 149
6.10 Applied BioCode ……………………………………………………………………………………………… 150
6.11 Atomo Diagnostics …………………………………………………………………………………………… 152
6.12 Aureum Diagnostics …………………………………………………………………………………………. 153
6.13 Aus Diagnostics ……………………………………………………………………………………………….. 154
6.14 Becton, Dickinson and Company …………………………………………………………………….. 155
6.15 Binx Health ………………………………………………………………………………………………………. 157
6.16 Biocartis …………………………………………………………………………………………………………… 159
6.17 BioFire Diagnostics (bioMérieux) ……………………………………………………………………….. 160
6.18 bioMérieux Diagnostics …………………………………………………………………………………….. 162
6.19 Bio-Rad Laboratories, Inc………………………………………………………………………………….. 165
6.20 Bosch Healthcare Solutions GmbH ……………………………………………………………………. 166
6.21 Cepheid (Danaher) …………………………………………………………………………………………. 167
6.22 Cue Health ………………………………………………………………………………………………………. 169
6.23 Curetis (OpGen) ………………………………………………………………………………………………. 171
6.24 DBS Systems …………………………………………………………………………………………………….. 172
6.25 Detect …………………………………………………………………………………………………………….. 173
6.26 Diagenode Diagnostics (Hologic) …………………………………………………………………….. 174
6.27 Diasorin S.p.A. ………………………………………………………………………………………………….. 175
6.28 Domus Diagnostics …………………………………………………………………………………………… 176
6.29 Ellume ……………………………………………………………………………………………………………… 177
6.30 Everywell …………………………………………………………………………………………………………. 178
6.31 Genomadix ……………………………………………………………………………………………………… 179
6.32 Getlabs……………………………………………………………………………………………………………. 180
6.33 Grip Molecular Technologies ……………………………………………………………………………. 181
6.34 Healthy.io ………………………………………………………………………………………………………… 182
6.35 Hologic ……………………………………………………………………………………………………………. 183
6.36 Inflammatix ……………………………………………………………………………………………………… 185
6.37 Invetech ………………………………………………………………………………………………………….. 186
6.38 Iollo …………………………………………………………………………………………………………………. 187
6.39 J&J Innovative Medicine ………………………………………………………………………………….. 188
6.40 Karius ………………………………………………………………………………………………………………. 189
6.41 Laboratory Corporation of America………………………………………………………………….. 190
6.42 Letsgetchecked ………………………………………………………………………………………………. 192
6.43 LightDeck Diagnostics ……………………………………………………………………………………… 193
6.44 Lucira Health (Pfizer) ………………………………………………………………………………………… 194
6.45 LumiraDx …………………………………………………………………………………………………………. 195
6.46 Meep ………………………………………………………………………………………………………………. 196
6.47 MFB Fertility ………………………………………………………………………………………………………. 197
6.48 myLabBox ……………………………………………………………………………………………………….. 198
6.49 NanoDx …………………………………………………………………………………………………………… 199
6.50 Nanomix ………………………………………………………………………………………………………….. 200
6.51 OraSure Technologies ………………………………………………………………………………………. 201
6.52 Oxford Nanopore Technologies ……………………………………………………………………….. 203
6.53 Panagene ……………………………………………………………………………………………………….. 205
6.54 Prenetics ………………………………………………………………………………………………………….. 206
6.55 Primerdesign (Novacyt) ……………………………………………………………………………………. 207
6.56 Prominex …………………………………………………………………………………………………………. 208
6.57 Proof Diagnostics ……………………………………………………………………………………………… 210
6.58 Qiagen ……………………………………………………………………………………………………………. 211
6.59 QuantuMDx …………………………………………………………………………………………………….. 213
6.60 Quest Diagnostics ……………………………………………………………………………………………. 214
6.61 QuidelOrtho …………………………………………………………………………………………………….. 215
6.62 Randox Toxicology …………………………………………………………………………………………… 217
6.63 Roche Diagnostics …………………………………………………………………………………………… 218
6.64 Salignostics ………………………………………………………………………………………………………. 220
6.65 SD Biosensor …………………………………………………………………………………………………….. 221
6.66 Seegene………………………………………………………………………………………………………….. 222
6.67 Siemens Healthineers ……………………………………………………………………………………….. 223
6.68 T2 Biosystems ……………………………………………………………………………………………………. 224
6.69 TestCard ………………………………………………………………………………………………………….. 225
6.70 Thermo Fisher Scientific …………………………………………………………………………………….. 226
6.71 Thriva ………………………………………………………………………………………………………………. 228
6.72 Visby Medical ………………………………………………………………………………………………….. 229
6.73 XCR Diagnostics ………………………………………………………………………………………………. 231
6.74 YourBio Health …………………………………………………………………………………………………. 233
7 Global Market Size …………………………………………………………………………………………… 234
7.1 Home Diagnostics Global Market Size by Country ……………………………………………… 235
7.1.1 Home Diagnostics Global Market Size by Country Table ………………………………… 235
7.1.2 Home Diagnostics Global Market Size by Country Chart ………………………………… 236
7.2 Home Diagnostics Global Market Size by Application ……………………………………….. 237
7.2.1 Home Diagnostics Global Market Size by Application Table …………………………… 237
7.2.2 Home Diagnostics Global Market Size by Application Share by Year ………………. 238
7.2.3 Home Diagnostics Global Market Size by Application Base vs Final ………………… 239
7.2.4 Home Diagnostics Global Market Size by Application Base Year …………………….. 240
7.2.5 Home Diagnostics Global Market Size by Application Final Year …………………….. 241
7.2.6 Home Diagnostics Global Market Size by Application Segment Growth …………. 242
7.3 Home Diagnostics Global Market Size by Channel ……………………………………………. 243
7.3.1 Home Diagnostics Global Market Size by Channel Table ……………………………….. 243
7.3.2 Home Diagnostics Global Market Size by Channel Share by Year …………………… 244
7.3.3 Home Diagnostics Global Market Size by Channel Base vs Final ……………………… 245
7.3.4 Home Diagnostics Global Market Size by Channel Base Year …………………………. 246
7.3.5 Home Diagnostics Global Market Size by Channel Final Year …………………………. 247
7.3.6 Home Diagnostics Global Market Size by Channel Segment Growth ………………. 248
7.4 Home Diagnostics Global Market Size by Technology ……………………………………….. 249
7.4.1 Home Diagnostics Global Market Size by Technology Table …………………………… 249
7.4.2 Home Diagnostics Global Market Size by Technology Share by Year ………………. 250
7.4.3 Home Diagnostics Global Market Size by Technology Base vs Final ………………… 251
7.4.4 Home Diagnostics Global Market Size by Technology Base Year…………………….. 252
7.4.5 Home Diagnostics Global Market Size by Technology Final Year …………………….. 253
7.4.6 Home Diagnostics Global Market Size by Technology Segment Growth …………. 254
8 Global Market by Application ………………………………………………………………………….. 255
8.1 Respiratory Market …………………………………………………………………………………………… 256
8.1.1 Respiratory Market by Country Table …………………………………………………………….. 256
8.1.2 Respiratory Market Chart ………………………………………………………………………………. 257
8.2 STD Market ………………………………………………………………………………………………………. 258
8.2.1 STD Market by Country Table ………………………………………………………………………… 258
8.2.2 STD Market Chart ………………………………………………………………………………………….. 259
8.3 UTI Market ……………………………………………………………………………………………………….. 260
8.3.1 UTI Market by Country Table …………………………………………………………………………. 260
8.3.2 UTI Market Chart …………………………………………………………………………………………… 261
8.4 Pregnancy Market …………………………………………………………………………………………… 262
8.4.1 Pregnancy Market by Country Table …………………………………………………………….. 262
8.4.2 Pregnancy Market by Chart ………………………………………………………………………….. 263
8.5 Ovulation Market …………………………………………………………………………………………….. 264
8.5.1 Ovulation Market by Country Table ………………………………………………………………. 264
8.5.2 Ovulation Market by Chart ……………………………………………………………………………. 265
8.6 DNA Market …………………………………………………………………………………………………….. 266
8.6.1 DNA Market by Country Table ………………………………………………………………………. 266
8.6.2 DNA Market Chart ………………………………………………………………………………………… 267
8.7 Other Market …………………………………………………………………………………………………… 268
8.7.1 Other Market by Country Table …………………………………………………………………….. 268
8.7.2 Other Market Chart ………………………………………………………………………………………. 269
9 Global Market by Channel ………………………………………………………………………………. 270
9.1 Store Market ……………………………………………………………………………………………………. 271
9.1.1 Store Market by Country Table ……………………………………………………………………… 271
9.1.2 Store Market Chart ……………………………………………………………………………………….. 272
9.2 Online Market ………………………………………………………………………………………………….. 273
9.2.1 Online Market by Country Table ……………………………………………………………………. 273
9.2.2 Online Market Chart …………………………………………………………………………………….. 274
9.3 Other Channel Market ……………………………………………………………………………………… 275
9.3.1 Other Channel by Country Table…………………………………………………………………… 275
9.3.2 Other Channel Market Chart ………………………………………………………………………… 276
10 Global Market by Technology ……………………………………………………………………… 277
10.1 Immunoassay Market ……………………………………………………………………………………….. 278
10.1.1 Immunoassay Market by Country Table ……………………………………………………… 278
10.1.2 Immunoassay Market Chart ………………………………………………………………………. 279
10.2 Chemistry Market …………………………………………………………………………………………….. 280
10.2.1 Chemistry Market by Country Table …………………………………………………………… 280
10.2.2 Chemistry Market Chart …………………………………………………………………………….. 281
10.3 Nucleic Acid Market ………………………………………………………………………………………… 282
10.3.1 Nucleic Acid Market by Country Table ………………………………………………………. 282
10.3.2 Nucleic Acid Market Chart ………………………………………………………………………… 283
10.4 Other Technology Market ………………………………………………………………………………… 284
10.4.1 Other Technology Market by Country Table ………………………………………………. 284
10.4.2 Other Technology Market Chart ………………………………………………………………… 285
11 Appendices ………………………………………………………………………………………………… 286
11.1 United States Medicare System: Clinical Laboratory Fees Schedule …………………… 286
11.2 The Most Used IVD Assays …………………………………………………………………………………. 381
11.3 The Highest Grossing Assays ……………………………………………………………………………… 386
Profiles of Key Players
6.1 1DropDiagnostics
6.2 23andME Inc.
6.3 Abbott Laboratories
6.4 Accel Diagnostics
6.5 ADT Biotech
6.6 Akonni Biosystems
6.7 AlphaBiolabs
6.8 Alveo Technologies
6.9 Anitoa
6.10 Applied BioCode
6.11 Atomo Diagnostics
6.12 Aureum Diagnostics
6.13 Aus Diagnostics
6.14 Becton, Dickinson and Company
6.15 Binx Health
6.16 Biocartis
6.17 BioFire Diagnostics (bioMérieux)
6.18 bioMérieux Diagnostics
6.19 Bio-Rad Laboratories, Inc
6.20 Bosch Healthcare Solutions GmbH
6.21 Cepheid (Danaher)
6.22 Cue Health
6.23 Curetis (OpGen)
6.24 DBS Systems
6.25 Detect
6.26 Diagenode Diagnostics (Hologic)
6.27 Diasorin S.p.A.
6.28 Domus Diagnostics
6.29 Ellume
6.30 Everywell
6.31 Genomadix
6.32 Getlabs
6.33 Grip Molecular Technologies
6.34 Healthy.io
6.35 Hologic
6.36 Inflammatix
6.37 Invetech .
6.38 Iollo
6.39 J&J Innovative Medicine
6.40 Karius
6.41 Laboratory Corporation of America
6.42 Letsgetchecked
6.43 LightDeck Diagnostics
6.44 Lucira Health (Pfizer)
6.45 LumiraDx
6.46 Meep
6.47 MFB Fertility
6.48 myLabBox
6.49 NanoDx
6.50 Nanomix
6.51 OraSure Technologies
6.52 Oxford Nanopore Technologies
6.53 Panagene
6.54 Prenetics
6.55 Primerdesign (Novacyt)
6.56 Prominex
6.57 Proof Diagnostics
6.58 Qiagen
6.59 QuantuMDx
6.60 Quest Diagnostics
6.61 QuidelOrtho
6.62 Randox Toxicology
6.63 Roche Diagnostics
6.64 Salignostics
6.65 SD Biosensor
6.66 Seegene
6.67 Siemens Healthineers
6.68 T2 Biosystems
6.69 TestCard
6.70 Thermo Fisher Scientific
6.71 Thriva
6.72 Visby Medical
6.73 XCR Diagnostics
6.74 YourBio Health
Table of Table
Table of Table
Table 1 Application Segment Definitions …………………………………………………………………………… 30
Table 2 Channel Segment Definitions ……………………………………………………………………………….. 30
Table 3 Technology Segment Definitions …………………………………………………………………………… 31
Table 4 Market Players by Type ……………………………………………………………………………………….. 40
Table 5 Clinical Laboratory Departments and Segments …………………………………………………… 46
Table 6 Laboratory Management Focus – Different Approaches ………………………………………. 47
Table 7 Key Segmentation Variables Going Forward…………………………………………………………. 48
Table 8 Possible Market Segments of HOME Market ………………………………………………………….. 48
Table 9 Five Factors Driving Growth ………………………………………………………………………………….. 56
Table 10 Four Factors Limiting Growth ………………………………………………………………………………. 59
Table 11 Self vs. Send TAT …………………………………………………………………………………………………. 65
Table 12 Home Diagnostics Global Market by Country/Region………………………………………… 235
Table 13 Home Diagnostics Global Market by Application ………………………………………………. 237
Table 14 Home Diagnostics Global Market by Channel …………………………………………………… 243
Table 15 Home Diagnostics Global Market by Technology ………………………………………………. 249
Table 16 Respiratory by Country……………………………………………………………………………………… 256
Table 17 STD market by country ……………………………………………………………………………………… 258
Table 18 UTI Market by country ………………………………………………………………………………………. 260
Table 19 Pregnancy Market by country ………………………………………………………………………….. 262
Table 20 Ovulation Market by country …………………………………………………………………………… 264
Table 21 DNA Market by country …………………………………………………………………………………… 266
Table 22 Other Market by country ………………………………………………………………………………….. 268
Table 23 Store Market by Country …………………………………………………………………………………. 271
Table 24 Online market by country ………………………………………………………………………………… 273
Table 25 Other Channel Market by country ……………………………………………………………………. 275
Table 26 Immunoassay by Country ………………………………………………………………………………… 278
Table 27 Chemistry Market by country ……………………………………………………………………………. 280
Table 28 Nucleic Acid Market by country ……………………………………………………………………….. 282
Table 29 Other Technology Market by country ……………………………………………………………….. 284
Table 30 Clinical Lab Fee Schedule ……………………………………………………………………………….. 286
Table 31 The Most Common Assays ……………………………………………………………………………….. 381
Table 32 Largest Revenue Assays ……………………………………………………………………………………. 386
Table of Figures
Figure 1 Standard Test Paradigm ……………………………………………………………………………………… 26
Figure 2 The New Test Paradigm ……………………………………………………………………………………… 27
Figure 3 Global Healthcare Spending ………………………………………………………………………………. 35
Figure 4 The Lab Test Pie ………………………………………………………………………………………………….. 36
Figure 5 The Road to Diagnostics ……………………………………………………………………………………… 39
Figure 6 Chart Death Rates and Infectious Disease Decline ………………………………………………. 60
Figure 6 The Multiplex Paradigm Shift………………………………………………………………………………… 63
Figure 8 Market Size by Country – Key Countries ………………………………………………………………. 236
Figure 9 Chart of Global Market by Application by Year …………………………………………………. 238
Figure 10 Application Segment Shares Base vs Final ………………………………………………………. 239
Figure 11 Application Share Base Year ………………………………………………………………………….. 240
Figure 12 Application Share Final Year ………………………………………………………………………….. 241
Figure 13 Application Segment Growth Rates ……………………………………………………………….. 242
Figure 14 Chart of Global Market by Channel by Year …………………………………………………….. 244
Figure 15 Channel Segment Shares Base vs Final …………………………………………………………….. 245
Figure 16 Channel Share Base Year ………………………………………………………………………………… 246
Figure 17 Channel Share Final Year ………………………………………………………………………………… 247
Figure 18 Channel Segment Growth Rates ……………………………………………………………………… 248
Figure 19 Chart of Global Market by Technology by Year ……………………………………………….. 250
Figure 20 Technology Segment Shares Base vs Final ………………………………………………………. 251
Figure 21 Technology Share Base Year ………………………………………………………………………….. 252
Figure 22 Technology Share Final Year ………………………………………………………………………….. 253
Figure 23 Technology Segment Growth Rates ……………………………………………………………….. 254
Figure 24 Chart – Respiratory Market Growth …………………………………………………………………… 257
Figure 25 Chart – STD Market Growth ……………………………………………………………………………… 259
Figure 26 Chart – UTI Market Growth ……………………………………………………………………………….. 261
Figure 27 Chart – Pregnancy Market Growth …………………………………………………………………… 263
Figure 28 Chart – Ovulation Market Growth …………………………………………………………………….. 265
Figure 29 Chart – DNA Market Growth ……………………………………………………………………………. 267
Figure 30 Chart – Other Market Growth ………………………………………………………………………….. 269
Figure 31 Chart – Store Market Growth ……………………………………………………………………………. 272
Figure 32 Chart – Online Market Growth …………………………………………………………………………. 274
Since 2001 Howe Sound Research is a market research and consulting company based in Vancouver, British Columbia, Canada. We publish market research reports that address scientific industries with an emphasis on Biotechnology, Medical Imaging, Pharmaceutical and Clinical Diagnostic markets. We consider ourselves experts in these areas. This contrasts with the many research mills that produce canned reports on the Handbag market one day and the X-ray market the next.
We approach market research differently than other companies. At any one time we have a limited number of reports and we update them two to four times a year. Our reports are prepared by people who understand the industry and have worked and studied in the area.
Our service goes beyond research reports. We often provide, at no extra cost, information that will help you apply our numbers to your unique situation. We’ve been doing this for years. Buying more than one report at a time can provide significant savings and upgraded licensing.
Our reports are sold on a 12 Month Subscription basis. Buying a report entitles you to the original current report plus an additional 1 to 3 follow on updated reports. At least one of these will include numbers and forecasts with an additional year. These reports are sent to you directly as they are released. This allows you to stay current on the situation and outlook in your area of interest. Your initial subscription can be renewed at a significantly discounted rate so that you can continue to keep on top of market developments. This program allows you to follow very specific market areas in detail in an ongoing and cost-effective way.
